NDSU Receives $2M For Pancreatic Cancer Research

Dr. Guodong Liu will work on the research team.
Dr. DK Srivastava is a co-PI on the NIH COBRE grant.

NDSU has received a $2M research grant to establish a Center of Biomedical Research Excellence focussed on pancreatic cancer. Profs. Sanku Malik (Pharmaceutical Sciences) and DK Srivastava (Chemistry and Biochemistry) are leading up the effort. Associate professor, Guodong Liu from the Department of Chemistry and Biochemistry will also participate on the research team.

Reported today in the Fargo Forum

FARGO — North Dakota State University has received a $2 million grant to establish a center to study pancreatic cancer, members of the North Dakota congressional delegation announced Wednesday.

The Center for Diagnostic and Therapeutic Strategies in Pancreatic Cancer will be in NDSU’s department of pharmaceutical sciences, Hoeven’s release said.

“This significant federal funding will allow NDSU pharmaceutical sciences researchers to advance cutting-edge science, which will help the medical community improve diagnosis and therapies for pancreatic cancer down the road,” Sen. Heidi Heitkamp said in a news release.

The funds will go toward pharmacology, physiology and biological chemistry research, Rep. Kevin Cramer said in a news release.